The chapter on psychopharmacology is especially strong, with abundant and sound clinical advice that blends the chapter authors’ clinical experience with their knowledge of the literature. I was pleased that they advise readers not to prescribe amoxapine; they might have added that it can be up to 15 times more lethal in overdose than even other tricyclics (another chapter states that antidepressant overdose is the most common method of suicide in the United States). In discussing adjunctive use of triiodothyronine in treating depression, they fail to mention that its half-life of 2–4 hours requires divided doses (it is my impression that most psychiatrists are unaware of this, which could be one reason that some studies find it ineffective). The chapter claims that all neuroleptics are equally effective; the authors should have added that molindone works only for some patients (but it has the advantage of not causing weight gain). The list of cytochrome P450 inducers that lower drug plasma levels omits smoked foods. The authors remind us that cigarettes are inducers of these isoenzymes—yet another reason our patients should stop smoking! There is no mention of genetically determined slow and rapid metabolizers of psychotropics; the CYP2D6 gene, for example, has more than 70 known variants. Generics get short shrift, although the exorbitant cost of drugs is a substantial factor in noncompliance for many patients. Another complication of prescribing an expensive drug is the greater risk that the patient will end up with a counterfeit drug, since counterfeit drugs represent an estimated 10% of the prescription medicines sold globally each year and counterfeiters have more to gain from imitating expensive drugs.